GlycoEra AG

https://www.glycoera.com

LinkedIn: https://www.linkedin.com/company/glycoera-ag

GlycoEra AG is a development-stage biotechnology company building a pipeline of transformative medicines for the treatment of a range of autoimmune diseases. GlycoEra’s innovative platform enables high-throughput design and production of candidates for fast and deep degradation of pathogenic proteins. The Company’s programs take advantage of selective and sustained removal of pathogenic proteins, which is highly relevant in a broad variety of additional settings, including oncology, neurology and infectious disease. *

	Start	2020-12-03 established (s-off)
	Group	GlycoEra (Group)
	Predecessor	LimmaTech Biologics AG
	Industry	CustomGlycan glycoengineering platform
	Industry 2	targeted protein degradation drug (TPD drug)
	Person	Kaundinya, Ganesh V. (GlycoEra 202205– CEO before Founder + COO + CSO of Momenta Pharmaceuticals)
	Person 2	Fralish, Greg (GlycoEra 202401– CBO before 2seventy Bio + Bluebird Bio + Takeda)

	Region	Wädenswil ZH
	Country	Switzerland
	Street	3 Grabenstr.
	City	8952 Schlieren ZH
	Tel	+41-44-733-8575
		Address record changed: 2024-01-06

Basic data	Employees	n. a.

		* Document for »About Section«: GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil.

		Record changed: 2024-12-29

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

More documents for GlycoEra (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)